The Zacks Analyst Blog Highlights: Tesla, Zoetis, Target, Boston Scientific and Moody's. 04-09 zacks.com - Chicago, IL – April 9, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stock Screener Industry Rank Best ETFs "A" Rated ETFs Best ETF Categories High Yield ETFs Zoetis completes deal to acquire Abaxis . ABAXIS, Inc. (ABAX) Today's Latest Price: $83.00 USD. 0.09 (-0.11%) Updated Jul 31 7:24pm. Add ABAX to Watchlist Sign Up. Research Abaxis, Inc. with InvestorGuide.com stock research tool. ABAX company news, press releases, articles, earnings targets, SEC filings, and insider trading. Get your free Abaxis Inc stock live and up-to-date data - ABAX Quote, charts, rates, analysis, news & forecasts. Enter Now! Here comes the data for ABAXIS Inc (ABAX). In the 52 weeks ending on 2018-08-01 the highest price reached by ABAXIS Inc (ABAX) stock was 83.5384. The lowest price was 43.4775. The daily prices are volatile. Hence, the highest one day price may be misleading. Hence some prefer looking at weekly and monthly averages (highest and lowest averages). Abaxis, Inc (ABAX) Stock Dividend Data. ABAX Stock Dividend Data. Dividend Yield Dividend Yield. Dividend yield is the relation between a stock’s annual dividend payout and its current stock price. Click here to learn more. 0.00% healthcare Average 0.00% ANNUALIZED PAYOUT Annualized Payout.
Description: Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements.
Abaxis, Inc. (Nasdaq: ABAX) Abaxis shareholders will receive only $83.00 in cash for each share of Abaxis stock they own. The investigation concerns whether the Board of Abaxis breached their fiduciary duties to shareholders and whether Zoetis is underpaying for the Company. Abaxis, Inc. | 5,614 followers on LinkedIn | Abaxis is a leader in the development and commercialization of leading-edge medical device and innovative technology and services that support best (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of 16/5/2018 · Zoetis Inc (NYSE: ZTS), an animal health company, announced a deal to acquire Abaxis Inc (NASDAQ: ABAX), a developer of portable blood analysis systems used in human or … Triumph Bancorp Inc. (NASD: TBK) will replace Abaxis Inc. (NASD: ABAX) in the S&P SmallCap 600 effective prior to the open of trading on Monday, August 6. Abaxis, Inc. (“us” or “we”) hereby incorporates by reference in this registration statement the following documents: (a) Our amended annual report on Form 10-K/A filed under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), containing audited financial statements for our fiscal year ended March 31, 2002 as filed with the Securities and Exchange Commission on Closing Stock Price USD 53.24: As of Date November 11, 2015: One Year Performance -0.49%: One Month Performance 15.11%: Industry Group Medical Specialties: 52 wk. Range USD 41.53 - 66.8859: Market Cap (Millions) USD 1,209.453: Total Shares Outstanding (Millions) 22.72: Latest Filing Dates: Annual March 31, 2015: Semi Annual N/A: Quarterly
Abaxis, Inc. (delisted) (ABAX) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
14 May 2014 will stock VetScan VS2 chemistry analyzers and diagnostic reagent discs under an agreement with equipment manufacturer Abaxis Inc. Abaxis is engaged in developing, manufacturing and marketing portable blood analysis systems for use in the human or veterinary patient-care to provide 29 Jul 2016 The aggregate market value of the voting stock held by non-affiliates of Abaxis as of September 30, 2015, the last business day of the second. 27 Apr 2017 Listen to "Q4 2017 Abaxis Inc Earnings Call". Download, follow and add "ABAXIS , Inc." earnings calls to your podcast at EarningsCast. 3 Mar 2017 We look forward to working with Abaxis to offer a comprehensive product and the U.S animal health business of Henry Schein, Inc. (NASDAQ:HSIC). branded products and Henry Schein private-brand products in stock, 6 Sep 2016 Air Worldwide Holdings NEW Common Stock|Q|20160906|C AB|Alliance Bernstein Holding L P|N|20160906|C ABAX|ABAXIS, Inc. Common Find the latest 139330 (ABAX) stock quote, history, news and other vital information to help you with your stock trading and investing.
6 Aug 2019 Taylor served as CFO at Abaxis, Inc. (Nasdaq: ABAX) from 2015 through the sale of the company to Zoetis in July 2018 . Abaxis was a diagnostic
16 May 2018 Zoetis Inc (NYSE: ZTS), an animal health company, announced a deal to acquire Own the Top-Performing Breakout Stock Every Month? 25 Nov 2019 Zoetis, Inc (ZTS-Free Report) announced the acquisition of ZNLabs, With this acquisition, Zoetis gained access to Abaxis' VetScan Zoetis' stock has surged 40% year to date compared with the industry's growth of 8.6%. Invest in stocks, options and ETFs (funds), all commission-free with the Robinhood app. Our trading tools give everyone access to the financial market - whether 30 Jun 2017 To date, Abaxis' Piccolo is the only point-of-care technology that can deliver comprehensive ABAXIS, Inc. (ABAX): Free Stock Analysis Report. 6 Aug 2019 Taylor served as CFO at Abaxis, Inc. (Nasdaq: ABAX) from 2015 through the sale of the company to Zoetis in July 2018 . Abaxis was a diagnostic 16 May 2018 Animal health company Zoetis said it would buy Abaxis, a maker of veterinary The stock has surged 45 percent since the start of the year.
Abaxis Inc (NASDAQ:ABAX) released its earnings results on Thursday, April, 26th. The medical research company reported $0.42 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.32 by $0.10.
Description: Abaxis, Inc. is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements.